Goelzer Investment Management Inc. lowered its stake in shares of The Cigna Group (NYSE:CI – Free Report) by 2.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 15,971 shares of the health services provider’s stock after selling 439 shares during the period. Goelzer Investment Management Inc.’s holdings in The Cigna Group were worth $4,410,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. IFG Advisors LLC grew its holdings in shares of The Cigna Group by 4.6% in the 3rd quarter. IFG Advisors LLC now owns 699 shares of the health services provider’s stock worth $242,000 after acquiring an additional 31 shares during the period. McClarren Financial Advisors Inc. grew its holdings in The Cigna Group by 4.7% in the third quarter. McClarren Financial Advisors Inc. now owns 692 shares of the health services provider’s stock valued at $240,000 after purchasing an additional 31 shares during the last quarter. SPC Financial Inc. increased its position in shares of The Cigna Group by 0.7% in the second quarter. SPC Financial Inc. now owns 5,119 shares of the health services provider’s stock valued at $1,692,000 after buying an additional 34 shares in the last quarter. Castle Rock Wealth Management LLC raised its stake in shares of The Cigna Group by 0.5% during the 3rd quarter. Castle Rock Wealth Management LLC now owns 6,651 shares of the health services provider’s stock worth $2,263,000 after buying an additional 34 shares during the last quarter. Finally, Adero Partners LLC grew its stake in The Cigna Group by 4.5% in the 3rd quarter. Adero Partners LLC now owns 788 shares of the health services provider’s stock valued at $273,000 after acquiring an additional 34 shares during the last quarter. 86.99% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of equities analysts have issued reports on CI shares. Truist Financial cut their target price on shares of The Cigna Group from $420.00 to $390.00 and set a “buy” rating for the company in a research report on Monday, January 6th. StockNews.com lowered The Cigna Group from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. Deutsche Bank Aktiengesellschaft dropped their price target on The Cigna Group from $398.00 to $394.00 and set a “buy” rating for the company in a research report on Monday, November 4th. Cantor Fitzgerald restated an “overweight” rating and issued a $400.00 price objective on shares of The Cigna Group in a research report on Wednesday, October 23rd. Finally, Piper Sandler reiterated an “overweight” rating and set a $394.00 price objective (up previously from $392.00) on shares of The Cigna Group in a research report on Tuesday, November 5th. One equities research analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and an average target price of $395.93.
The Cigna Group Price Performance
The Cigna Group stock opened at $294.18 on Friday. The Cigna Group has a 1 year low of $262.03 and a 1 year high of $370.83. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.72 and a current ratio of 0.72. The firm has a 50 day moving average price of $297.72 and a 200 day moving average price of $325.82. The company has a market cap of $81.83 billion, a price-to-earnings ratio of 27.75, a PEG ratio of 0.78 and a beta of 0.54.
The Cigna Group (NYSE:CI – Get Free Report) last announced its quarterly earnings data on Thursday, October 31st. The health services provider reported $7.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.22 by $0.29. The company had revenue of $63.70 billion during the quarter, compared to analysts’ expectations of $59.58 billion. The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. The business’s quarterly revenue was up 29.8% compared to the same quarter last year. During the same period in the previous year, the company earned $6.77 EPS. Sell-side analysts predict that The Cigna Group will post 28.5 earnings per share for the current year.
About The Cigna Group
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Further Reading
- Five stocks we like better than The Cigna Group
- What is MarketRankā¢? How to Use it
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- 3 Buy-and-Hold Stocks for Long-Term Growth
- How to Calculate Stock Profit
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.